Remed Co.Ltd - Asset Resilience Ratio

Latest as of March 2026: 4.13%

Remed Co.Ltd (302550) has an Asset Resilience Ratio of 4.13% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Remed Co.Ltd to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩2.26 Billion
≈ $1.53 Million USD Cash + Short-term Investments

Total Assets

₩54.74 Billion
≈ $37.10 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2017–2025)

This chart shows how Remed Co.Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 302550 total asset value.

Liquid Assets Composition Over Time

This chart breaks down Remed Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Remed Co.Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩2.26 Billion 4.13%
Total Liquid Assets ₩2.26 Billion 4.13%

Asset Resilience Insights

  • Limited Liquidity: Remed Co.Ltd maintains only 4.13% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Remed Co.Ltd Industry Peers by Asset Resilience Ratio

Compare Remed Co.Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.84%
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 34.37%
Stratec SE
XETRA:SBS
Medical Devices 0.29%
Shinhung
KO:004080
Medical Devices 4.17%
DRTECH Corporation
KQ:214680
Medical Devices 5.18%
Novacyt
PA:ALNOV
Medical Devices 0.02%
Diagnostic Medical Systems SA
PA:ALDMS
Medical Devices 1.48%

Annual Asset Resilience Ratio for Remed Co.Ltd (2017–2025)

The table below shows the annual Asset Resilience Ratio data for Remed Co.Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 8.46% ₩4.56 Billion
≈ $3.09 Million
₩53.91 Billion
≈ $36.53 Million
-9.62pp
2024-12-31 18.08% ₩10.68 Billion
≈ $7.24 Million
₩59.06 Billion
≈ $40.03 Million
+10.19pp
2023-12-31 7.89% ₩4.35 Billion
≈ $2.95 Million
₩55.06 Billion
≈ $37.31 Million
-31.31pp
2022-12-31 39.20% ₩30.63 Billion
≈ $20.76 Million
₩78.13 Billion
≈ $52.94 Million
-7.97pp
2021-12-31 47.17% ₩36.42 Billion
≈ $24.68 Million
₩77.20 Billion
≈ $52.32 Million
-9.50pp
2020-12-31 56.67% ₩41.64 Billion
≈ $28.22 Million
₩73.47 Billion
≈ $49.79 Million
+13.13pp
2019-12-31 43.54% ₩15.22 Billion
≈ $10.31 Million
₩34.95 Billion
≈ $23.68 Million
+14.33pp
2018-12-31 29.21% ₩6.28 Billion
≈ $4.26 Million
₩21.51 Billion
≈ $14.58 Million
+6.47pp
2017-12-31 22.74% ₩2.86 Billion
≈ $1.94 Million
₩12.59 Billion
≈ $8.53 Million
--
pp = percentage points

About Remed Co.Ltd

KQ:302550 Korea Medical Devices
Market Cap
$53.86 Million
₩79.47 Billion KRW
Market Cap Rank
#21729 Global
#1306 in Korea
Share Price
₩2625.00
Change (1 day)
-0.38%
52-Week Range
₩2485.00 - ₩3710.00
All Time High
₩4180.00
About

Remed Co.,Ltd. engages in the manufacture and supply of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as stroke, autism, dementia, Parkinson's disease, developmental disorders, and tinnitus. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells,… Read more